课题基金 / 基金详情

Growth Regulation of Activated T Cells by FADD

Growth Regulation of Activated T Cells by FADD
FADD 对活化 T 细胞的生长调节
批准号:
6683606
负责人:
Craig Michael Walsh
金额:
$26.21万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2007-11-30

项目摘要

项目成果

Craig Michael Walsh的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在免疫反应过程中,T细胞面临许多阶段,在这些阶段中,在生存、增殖和死亡之间做出适当的决定是至关重要的。尽管这些选择中的许多都受到不同的信号转导途径的调控,但越来越明显的是,控制这些不同途径的一些分子是共同的。我们发现了一条涉及FADD/Mort1的新途径,它将T细胞的凋亡控制与细胞生长控制联系起来。FADD是一种细胞质适配分子,与死亡受体和caspase-8和-10物理上相关;这种联系导致caspase激活。使用在T细胞中表达突变形式的FADD的小鼠,我们已经证明了这种凋亡诱导分子对于正常的T细胞对一些有丝分裂刺激的反应是关键的。我们在这项建议中概述了几种方法,以更充分地了解FADD协调T细胞增殖和凋亡之间的选择的方法。在这个方案中,我们将首先确定在正常背景下已经分化的T细胞的增殖是否需要FADD。这将使我们能够区分FADD在T细胞发育中的作用和它在成熟的外周T细胞中作为共刺激信号成分的潜力。接下来,我们将在表达显性阴性FADD的T细胞的背景下研究已知信号通路的激活,以确定FADD如何参与建立和维持增殖的CD4和CD8T细胞。我们还将通过将显性-阴性形式的caspase-8引入原代T细胞来探讨caspase-8可能在这种依赖FADD的共刺激过程中发挥作用的可能性。此外,我们将研究caspase-8的差异处理,以了解该分子如何在T细胞反应中诱导和维持增殖,并随后增强激活诱导的细胞死亡。FADD调节T细胞增殖和凋亡的机制是一个谜。然而,很明显,免疫系统的这一部分的增殖和凋亡调节对于避免癌症、自身免疫和发病机制至关重要。因此,这些拟议研究的结果不仅将阐明连接这两个过程的一个重要分子,而且还将突出一个对逃避人类疾病至关重要的信号范式。
英文摘要
DESCRIPTION (provided by applicant): During the course of an immune response, T cells are confronted with a number of stages where appropriate decisions between survival, proliferation and death are crucial. Although many of these choices are regulated by distinct signal transduction pathways, it is becoming clear that some of the molecules regulating these disparate pathways are shared in common. We have discovered a novel pathway involving FADD/Mortl, that links apoptotic control in T cells to cellular growth control. FADD is a cytoplasmic adapter molecule that physically associates with death receptors and caspase-8 and -10; this association results in caspase activation. Using mice expressing a mutant form of FADD in T cells, we have demonstrated that this apoptosis-inducing molecule is critical for normal T cell responsiveness to a number of mitogenic stimuli. We outline several approaches in this proposal to more fully understand the means by which FADD coordinates the choice between proliferation and apoptosis in T cells. In this proposal, we will first determine if FADD is required for the proliferation of T cells that have differentiated in a normal background. This will allow us to distinguish the role of FADD in the development of T cells from its potential to act as a costimulatory signaling component in mature peripheral T cells. Next, we will study the activation of known signaling pathways in the context of T cells expressing dominant negative FADD to determine how FADD participates in the institution and maintenance of proliferating CD4+ and CD8+ T cells. We will also address the potential that caspase-8 may play a role in this FADD-dependent costimulatory process by introducing dominant-negative forms of caspase-8 into primary T cells. Further, we will study the differential processing of caspase-8 to understand how this molecule might induce and maintain proliferation in a T cell response and later, potentiate activation-induced cell death. The mechanism by which FADD regulates both proliferation and apoptosis in T cells is an enigma. However, it is clear that both proliferative and apoptotic regulation of this compartment of the immune system is crucial for the avoidance of cancers, autoimmunity and pathogenesis. Therefore, results from these proposed studies will not only shed light on an important molecule linking these two processes, but will also highlight a signaling paradigm that is critical for the evasion of human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperion multi-parameter high-dimensional imaging mass cytometry platform
  • 批准号:
    10193821
  • 项目类别:
  • 资助金额:
    $59.99万
  • 财政年份:
    2021
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
  • 批准号:
    8093107
  • 项目类别:
  • 资助金额:
    $22.91万
  • 财政年份:
    2010
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
  • 批准号:
    7917835
  • 项目类别:
  • 资助金额:
    $3.44万
  • 财政年份:
    2009
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
  • 批准号:
    7430248
  • 项目类别:
  • 资助金额:
    $4.5万
  • 财政年份:
    2007
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
海外基金